News

Dr Joshua Nass, of the Michigan Institute for Neurological Disorders, discussed the 10 most common signs of ailing health ...
Investing.com - Jefferies has raised the price target on Dr. Reddy’s Laboratories Ltd. (DRRD:IN) (NYSE:RDY) to INR1,100.00 from INR1,010.00 while maintaining an Underperform rating on the stock. The p ...
Not all the news was good. D.R. Horton beat earnings soundly, but its $3.36 per share profit still declined 18% versus Q3 ...
Infosys, Coforge, Dr Reddy's Lab, Bajaj Housing Finance, Bikaji Foods, Tata Consumer Products among 58 companies to release ...
Dr Reddy's Laboratories reported a 1% rise in net profit for the June quarter, with revenues increasing from Rs 7,673 crore to Rs 8,545 crore. Despite facing pricing pressures in the US generic market ...
This 27% rise for KDP stock since late 2019 can primarily be attributed to 1.Keurig Dr Pepper’s revenue rising 17% to $13 billion over the last twelve months, compared to $11 billion in 2019, 2 ...